Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine in Early Sepsis
NCT03129542Phase 1Completed
- Sponsor
- Mayo Clinic
- Start
- Aug 2017
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of midodrine in sepsis, sponsored by Mayo Clinic. Primary endpoint: Duration of Vasopressor Use at 24 hours. Started Aug 2017; status: completed.
02
Drugs
midodrine
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT03129542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03129542.